Table 2 Antibodies used in the study.

From: MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression

Primary antibodies

Catalog number/distributor

Dilution

Secondary antibodies (Catalog number/distributor)

Anti-rabbit IgG-HRP 7075P2/CST, EE. UU.

Anti-mouse IgG-HRP 115-035-003/JIR, EE. UU.

Anti-c-Met

D1C2/CST EE. UU.

1:1000

1:3000

Anti-Gab1

3232/CST, EE. UU.

1:1000

1:5000

Anti-phospho Gab1(Tyr-307)

3234/CST, EE. UU.

1:3000

1:5000

Anti-Fak

D2R2E-13009/CST, EE. UU.

1:3000

1:5000

Anti-phospho Fak (Tyr-397)

D20B1-8556/CST, EE. UU.

1:1000

1:5000

Anti-GAPDH

(6C5)-sc-32233/SCBT, EE. UU.

1:1000

1:20,000

  1. CST: Cell Signaling Technology; SCBT: Santa Cruz Biotechnology; JIR: Jackson ImmunoResearch.